España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Avidity Biosciences
RNA
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$40.37
1.75
4.53%
At Close: -
$40.37
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Avidity Biosciences (RNA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Avidity Biosciences (NASDAQ:RNA) Stock
Avidity Biosciences Stock (NASDAQ: RNA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 01, 2024
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Piero Cingari
Thursday, June 20, 2024
(RNA) - Analyzing Avidity Biosciences's Short Interest
Benzinga Insights
Sunday, June 16, 2024
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
Lekha Gupta
Friday, June 14, 2024
Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
Avi Kapoor
Reported Earlier, Avidity Biosciences Prices ...
Benzinga Newsdesk
Thursday, June 13, 2024
Avidity Up 33% on Rare Muscle Disease Study Results
Zacks
B of A Securities Maintains Buy on Avidity Bi...
Benzinga Newsdesk
Wednesday, June 12, 2024
Avidity Bioscience Announces Proposed Public ...
Benzinga Newsdesk
Needham Maintains Buy on Avidity Biosciences,...
Benzinga Newsdesk
Crude Oil Moves Higher; Vera Bradley Shares Slide
Avi Kapoor
Chardan Capital Maintains Buy on Avidity Bios...
Benzinga Newsdesk
Evercore ISI Group Maintains Outperform on Av...
Benzinga Newsdesk
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Nasdaq Jumps 300 Points; Oracle Shares Spike Higher
Avi Kapoor
Why Avidity Biosciences Shares Are Trading Higher Wednesday
Dylan Berman
Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Market-Moving News for June 12th
Benzinga Newsdesk
Avidity shares are trading higher after the c...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Avidity Reports Over 50% Reduction In DUX4 Re...
Benzinga Newsdesk
Monday, June 10, 2024
A Glimpse Into The Expert Outlook On Avidity Biosciences Through 6 Analysts
Benzinga Insights
Needham Reiterates Buy on Avidity Biosciences...
Benzinga Newsdesk
Wednesday, May 29, 2024
Avidity Biosciences To Present Preliminary Da...
Benzinga Newsdesk
Friday, May 10, 2024
Chardan Capital Maintains Buy on Avidity Bios...
Benzinga Newsdesk
Needham Reiterates Buy on Avidity Biosciences...
Benzinga Newsdesk
Wednesday, May 08, 2024
Avidity Biosciences Receives FDA Breakthrough...
Benzinga Newsdesk
Friday, May 03, 2024
Navigating 7 Analyst Ratings For Avidity Biosciences
Benzinga Insights
Avidity Biosciences shares are trading higher...
Benzinga Newsdesk
B of A Securities Initiates Coverage On Avidi...
Benzinga Newsdesk
Thursday, April 18, 2024
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
Johnny Rice
-
Sponsored
Thursday, April 11, 2024
Where Avidity Biosciences Stands With Analysts
Benzinga Insights
Needham Reiterates Buy on Avidity Biosciences...
Benzinga Newsdesk
Tuesday, April 02, 2024
Avidity Biosciences Filed Prospectus For Proposed Resale Or Other Disposition By Selling Securityholders Of Up To 15.2M Shares Of Common Stock; Prospectus For Up To 9M Shares Issuable Upon Exercise Of Pre-funded Warrants
Charles Gross
Thursday, March 14, 2024
Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
Vandana Singh
Cantor Fitzgerald Initiates Coverage On Avidi...
Benzinga Newsdesk
Tuesday, March 05, 2024
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
A Closer Look at 5 Analyst Recommendations For Avidity Biosciences
Benzinga Insights
Chardan Capital Maintains Buy on Avidity Bios...
Benzinga Newsdesk
Monday, March 04, 2024
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Needham Reiterates Buy on Avidity Biosciences...
Benzinga Newsdesk
Avidity Biosciences Says Lead Program Shows Reversal Of Disease Progression In Neuromuscular Disease
Vandana Singh
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Avidity Biosciences Announced New Long-term A...
Benzinga Newsdesk
Thursday, February 29, 2024
Avidity Biosciences shares are trading higher...
Benzinga Newsdesk
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Top 3 Health Care Stocks You May Want To Dump In Q1
Avi Kapoor
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
Piero Cingari
Needham Reiterates Buy on Avidity Biosciences...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch